196 related articles for article (PubMed ID: 31120000)
1. Coreceptor-Based Hematopoietic Stem Cell Gene Therapy for HIV Disease.
Hu J; Feng Y; Ma P; Lai Y
Curr Stem Cell Res Ther; 2019; 14(7):591-597. PubMed ID: 31120000
[TBL] [Abstract][Full Text] [Related]
2. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
Lai Y
Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic-stem-cell-based gene therapy for HIV disease.
Kiem HP; Jerome KR; Deeks SG; McCune JM
Cell Stem Cell; 2012 Feb; 10(2):137-47. PubMed ID: 22305563
[TBL] [Abstract][Full Text] [Related]
4. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
Allers K; Schneider T
Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Gupta RK; Abdul-Jawad S; McCoy LE; Mok HP; Peppa D; Salgado M; Martinez-Picado J; Nijhuis M; Wensing AMJ; Lee H; Grant P; Nastouli E; Lambert J; Pace M; Salasc F; Monit C; Innes AJ; Muir L; Waters L; Frater J; Lever AML; Edwards SG; Gabriel IH; Olavarria E
Nature; 2019 Apr; 568(7751):244-248. PubMed ID: 30836379
[TBL] [Abstract][Full Text] [Related]
6. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
[TBL] [Abstract][Full Text] [Related]
7. CCR5 as a natural and modulated target for inhibition of HIV.
Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
[TBL] [Abstract][Full Text] [Related]
8. Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.
Ding J; Liu Y; Lai Y
Front Immunol; 2021; 12():688747. PubMed ID: 34122453
[TBL] [Abstract][Full Text] [Related]
9. Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection.
Wang J; Holmes MC
Cytotherapy; 2016 Nov; 18(11):1370-1381. PubMed ID: 27745602
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptors and HIV.
Broder CC; Collman RG
J Leukoc Biol; 1997 Jul; 62(1):20-9. PubMed ID: 9225988
[TBL] [Abstract][Full Text] [Related]
11. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
12. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation.
Prator CA; Donatelli J; Henrich TJ
Curr HIV/AIDS Rep; 2020 Aug; 17(4):385-393. PubMed ID: 32519184
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
14. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.
Peterson CW; Younan P; Jerome KR; Kiem HP
Gene Ther; 2013 Jul; 20(7):695-702. PubMed ID: 23364313
[TBL] [Abstract][Full Text] [Related]
16. Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?
Younan P; Kowalski J; Kiem HP
Mol Ther; 2014 Feb; 22(2):257-264. PubMed ID: 24220323
[TBL] [Abstract][Full Text] [Related]
17. Novel cell and gene therapies for HIV.
Hoxie JA; June CH
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028130
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression.
Shen H; Cheng T; Preffer FI; Dombkowski D; Tomasson MH; Golan DE; Yang O; Hofmann W; Sodroski JG; Luster AD; Scadden DT
J Virol; 1999 Jan; 73(1):728-37. PubMed ID: 9847379
[TBL] [Abstract][Full Text] [Related]
19. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
